Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani(Unknown), Hyacinth-John Abu(University of Dundee), Mai Abedalla, Mahmoud Abouibrahim, Sadia Abbasi, Ahmed Abou-Haggar, Abraheem Abraheem, Kasim Abbas, Althaf Abdul Rasheed, Yazeed Abed El Khaleq, Ammar Abdelaziz, Alison Abbott, Alfie Abbott, Basir Abdul, Nabeel Abdallah, Rasheed Abdul-Raheem, Mustafa Abbas, Niyaz Abdulshukkoor, Kula Abdusamad, Christopher Aboah, A Abeer Ul Amna, Rebecca Abrams, A Abousamra, K Abouelela, Lynn Abel, Bushra Abdelqader, Miriam Abraham, Hani Abo-Leyah(University of Dundee), Joshua Abbas, A Abdul(Wrightington, Wigan and Leigh NHS Foundation Trust), Ashraf Omar Abdelaziz(Ain Shams University), Adebanke Aboaba, Fatima Abbas, Katrina Abernethy, Mohamed A. O. Abdelfattah, Movin Abeywickrema, A Aboagye-Odei, Mona Abouzaid, Abdulfatahi Abdulmumeen, Heba Aboelela, C Abhinaya, Rezan A. Kadir(The Royal Free Hospital), Ali Abbas(University of Dundee), Abdullah Abdullah, Affyarsyah Abidin, J Abrams, Hakam Abbass, Siddiqui Abdul(Wrightington, Wigan and Leigh NHS Foundation Trust), Tizzy Abraham, Abdulakeem Ajibode
Cited by 132
Related Papers
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2021|564
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|523
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2022|384